SH

SHINIL PHARMACEUTICAL CO., LTD.

012790 | KO

Overview

Corporate Details

ISIN(s):
KR7012790002
LEI:
Country:
South Korea
Address:
충북 충주시 앙성면 본평리 산 5-1, 충주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 841.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 876.9 KB
2025-03-24 00:00
AGM Information
정기주주총회결과
Korean 22.2 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 17.2 KB
2025-03-14 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.8 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 87.0 KB
2025-03-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 9.3 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 740.8 KB
2024-08-09 00:00
Interim / Quarterly Report
반기보고서 (2024.06)
Korean 738.9 KB
2024-06-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 788.8 KB

Automate Your Workflow. Get a real-time feed of all SHINIL PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SHINIL PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SHINIL PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

REGENXBIO Inc. Logo
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX
Rein Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.
United States of America
RNTX
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel
REKA
Relay Therapeutics, Inc. Logo
Developing precision medicines for oncology & genetic diseases by analyzing protein motion.
United States of America
RLAY
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland
RLF
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia
REPL
REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America
RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea
102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America
RZLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.